Canada Markets closed

Loncar Cancer Immunotherapy ETF (CNCR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.13+0.34 (+1.22%)
At close: 4:00PM EDT
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    CNCR reached a 52 Week high at 30.07
  • Y
    Yahoo Finance Insights
    CNCR reached a 52 Week high at 28.97
  • V
    Valueinvest
    Ouch
  • Y
    Yahoo Finance Insights
    CNCR reached a 52 Week high at 29.63
  • B
    Biogemfinder
    $GILD conversation
    The fools who are not scientifically educated and don't know apples from statistics deserve to lose money. I have just doubled down my position for several reasons:

    1. If GILD didn't think Remdisivir had any chance of working, they would not be producing and providing it free for multiple trials in multiple countries with 1000s of patients.
    2. 250 patient open trial with no proper control diodes tell squat about drugs efficacy..and its in China? How many times does the FDA approve drugs based on trials conducted in China or Russia (exclusively)? NONE!!!
    3. GILD has many shots on this COVID-19 goal. Remdisivir has a very good chance (way more than 50/50 I think). Regardless of the outcome in next few weeks, GILD is developing neutralizing antibodies for treatment. For the scientifically challenged people frequenting these borads, its a treatment that will effectively "neutralize" live viruses so that it cannot replicate and even remove from patients blood.
    4. Being a extremely successful anti-viral company (anti-HepC, HepB, HIV among others), I am 100% certain they have huge # of potential candidates that can be effective against the COVID-19 virus. This will take a little more time. but you can bet anything the experiments are being conducted right now to find a few winners to take them to the next level. Any promising ones will be fast-tracked like never before and will be approved within a year!!
    5. The current pipeline and approved drugs their revenues and the cash pile is reason enough to buy this stock, there is not much downside.

    Of course do your own DD but GILD has way better risk/reward ratio than any other biotechs out there.

    $GILD $TSLA $XBI $QQQ $IBB $BBH $BBC $FBT $LABU $LABD $PBE $CNCR $BIB $BIC
  • m
    mac
    maybe not here but this guy (Brad Loncar) was dead wrong about the celgene Squibb deal. Hope he sells all his shares, as he is not a good judge of value
  • b
    bruce
    This is the worst ETF never gets any traction and fund management continues to underperform!
  • b
    bruce
    Market up over 300 and this is down again. Make some portfolio changes here!
  • Y
    Yahoo Finance Insights
    CNCR reached a 52 Week low at $18.60
  • S
    STARWOOD
    This is a screaming buy!
  • b
    bruce
    Array Biopharma was up 87 % recently of course it isn't in the fund!
  • Y
    Yahoo Finance Insights
    CNCR reached an all time low at $17.43
  • Y
    Yahoo Finance Insights
    CNCR is down 5.35% to $20.63
  • R
    Rotor
    Good to buy. I think money is nothing, when exists a chance to be cured!
  • S
    STARWOOD
    This has turned into junk!
  • b
    bruce
    Market up this is down again !
  • Y
    Yahoo Finance Insights
    CNCR reached a 52 Week high at 25.13
  • Y
    Yahoo Finance Insights
    CNCR reached a 52 Week high at 26.07
  • S
    STARWOOD
    Down for the year so far!
  • S
    STARWOOD
    Hey Brad very nice turn around in this fund! Much better selection of what's included now. Thanks and keep up the good work!